Head-to-head · Value Score
CoreAge Rx vs Invyncible
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 81, Invyncible a 68. Here's what each one really costs past month one — and where each one bites back.
CoreAge Rx
Grade B · Good Value
Advertised price
From $79/mo
From $79/mo (compounded semaglutide; confirm total at checkout)
Invyncible
Grade C · Watch List
Advertised price
From $135
From $135 (starting semaglutide program with glycine + B12; price rises with dose)
The verdict
CoreAge Rx takes it on Value Score, 81 to 68 — an est. From $79/mo (compounded semaglutide; confirm total at checkout) first month, though we flag its pricing to watch. Invyncible isn't out of it: Someone who wants to read the price of every dose program, and the name of the pharmacy filling it, before handing over any details.
CoreAge Rx is a featured partner of this site. Its advertised prices have checkout conditions, and state eligibility is confirmed during intake.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Invyncible |
|---|---|---|
| Value Score | 81 (B) | 68 (C) |
| Advertised price | From $79/mo (compounded semaglutide; confirm total at checkout) | From $135 (starting semaglutide program with glycine + B12; price rises with dose) |
| Save vs brand self-pay | — | — |
| Semaglutide | From $79/mo (compounded injection; confirm total at checkout) | From $135 (starting 0.45 mg program with glycine + B12; no supply length stated) · plain semaglutide from $175 for a 2.5 mg vial (about 5 weeks) · oral capsules $365/mo |
| Tirzepatide | From $129/mo (compounded injection; confirm total at checkout) | From $165 per 4 weeks (2.5 mg weekly, with glycine + B12) · plain tirzepatide from $190 per 4 weeks |
| Both molecules | Yes | Yes |
| Pricing | Watch | Watch |
| Coverage | U.S., state limits shown at intake | Varies by product: six to nine states excluded |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
CoreAge Rx advertises compounded semaglutide from $79 and tirzepatide from $129 per month, with dose-flat pricing stated in its FAQ. Confirm the total and refund terms before paying.
What's good
- CoreAge Rx publishes separate product prices for both molecules: semaglutide from $79 per month and tirzepatide from $129. That gives you two actual medication offers to compare rather than one generic GLP-1 starting figure.
- CoreAge Rx's FAQ says the price locked in at checkout stays the same in future months regardless of dose increases. I would save that confirmation with the order, because a low starting price matters much more when the prescribed maintenance dose costs the same.
- The product pages state that there are no long-term contracts or membership fees and advertise fast, free delivery. Compare those inclusions with the checkout total; the refund policy separately allows applicable consultation fees and shipping charges if disclosed there.
- CoreAge Rx uses the MD Integrations professional entities for medical care and prescribing. Its FAQ names physicians assigned in California, Massachusetts, Rhode Island and Vermont, giving patients in those states a concrete medical contact to verify.
- CoreAge Rx offers account-based reordering and cancellation, and its help center says optional subscriptions can be managed in the member portal. Check whether your selected purchase is a one-time order or an automatically renewed subscription so the next charge is predictable.
- CoreAge Rx also advertises microdosing products at $79 for semaglutide and $129 for tirzepatide. These are separate lower-dose offers, not a reason to select your own dose or evidence that they work like the doses studied for approved products.
The fine print
- CoreAge Rx's FAQ promises an automatic 100% refund if the clinician declines your prescription, but its refund policy says applicable consultation fees of $50–$100 are nonrefundable. Ask which policy applies to the exact order and how much would be returned before you pay.
- CoreAge Rx's refund policy makes a medication order final once the prescription is approved and sent to the pharmacy, which can happen before shipping. Waiting until the parcel is dispatched may be too late to cancel an order or recover the medication charge. The policy also imposes a 30-day nonrefundable cutoff even when incomplete documentation has prevented fulfillment.
- CoreAge Rx does not publish a complete GLP-1 state list. Its FAQ says therapy-specific state restrictions are confirmed during intake, so a U.S. address alone does not establish that your selected medication is available where you live.
- CoreAge Rx does not name the dispensing pharmacy in its FAQ; it asks patients to contact support. Obtain the pharmacy's legal name, license and contact information before choosing a compounded prescription. The platform's branding does not identify who prepares your medication.
- CoreAge Rx's FAQ says there are no automatic rebills, while its refund policy and help center describe optional automatic renewals. I would confirm the selected purchase option and next charge date rather than treat the general FAQ answer as a guarantee for every order.
- CoreAge Rx offers compounded medication, which is not FDA-approved. Its FAQ says tirzepatide is typically formulated with B12 and that requests without it go to the prescriber. Ask why the exact formulation is appropriate for you; an added vitamin does not itself establish a lawful patient-specific difference.
Invyncible
Invyncible is a Florida-based telehealth brand operated by Nationwide Telemedicine, LLC, publishing the price of every compounded semaglutide and tirzepatide dose program on its open catalog.
What's good
- Invyncible prices every dose program on its open catalog, with no account or quiz, and the product page re-prices as you change dose.
- Invyncible names six compounding pharmacies with addresses and phone numbers, and names the specific pharmacy on some product pages, such as Partell Pharmacy for its capsules.
- Brand-name pens are stocked beside compounded at Invyncible: Wegovy at $1,750 and Zepbound at $1,540, plus an oral semaglutide capsule program at $365 a month.
- Invyncible's tirzepatide programs state their supply plainly: each dose step is a 4-week vial, from $165 with glycine and B12 or $190 plain.
- Invyncible names its operating company, Nationwide Telemedicine, LLC, and publishes consent, privacy, shipping and terms documents separately.
The fine print
- Every Invyncible price is shown against a permanent struck-through figure, which is anchoring rather than a saving.
- Invyncible's price rises with the dose: the $135 and $165 entry figures are the starting programs only.
- Invyncible's cheapest semaglutide program states no supply length, so it cannot be turned into a monthly rate from the page.
- State limits at Invyncible differ by product: plain semaglutide is unavailable in nine states and the glycine + B12 versions in six, so check your state on each page.
- Invyncible gives no 503A or 503B designation for its named pharmacies, and compounded medicine is not FDA-approved.
We earn a commission when you start treatment through some links on this site, at no extra cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Invyncible.
More head-to-heads
The programs scoring closest to this pair, side by side.
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. "% vs brand-name self-pay" compares a program's lowest disclosed monthly price against $349/mo, Wegovy's self-pay price at NovoCare Pharmacy, every standard dose after the two-month intro offer (checked October 2026). Prices change — confirm on each provider's site. Not medical advice; see our disclosure.